Jason Yeo, 54, a travelling sales manager from Devon, was shocked to discover his diagnosis in April 2024. He previously ...
PAM50, a genomic biomarker test, can classify prostate cancers into subtypes luminal B and non-luminal B, predicting which ...
Patients with D2T-PsA can be stratified into inflammatory and noninflammatory phenotypes, with the former linked to higher sonographic activity.
Morrow is now devoting his life to prostate cancer advocacy and urging other younger, high-risk men to get screened early. He ...
This early stage is often detected through routine screenings, such as a prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE), before any symptoms arise. Because the disease is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results